Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thaker

Showing results (91-100 of 256) with videos related to

Pageof 26
Sort By:
Gynecologic Oncology|October 22, 2008
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancerRebecca A Brooks, Janet S Rader, Farrokh Dehdashti, et al.
Annals of Surgical Oncology|September 6, 2014
Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancerL M Kuroki, M Mangano, J E Allsworth, et al.
Gynecologic Oncology|January 21, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcomaMichael D Toboni, Kaitlyn Dinkins, Sharon Wu, et al.
Gynecologic Oncology Reports|November 14, 2019
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumabJ Gillen, K A Mills, J Dvorak, et al.
Gynecologic and Obstetric Investigation|April 12, 2017
Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and TreatmentYevgeniya J Ioffe, Leslie Stewart Massad, Matthew A Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
EphA2 expression is associated with aggressive features in ovarian carcinomaPremal H Thaker, Michael Deavers, Joseph Celestino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2014
Targeting those with decreased meaning and peace: a supportive care opportunityAlaina J Brown, Charlotte C Sun, Diana Urbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptorsPremal H Thaker, Sertac Yazici, Monique B Nilsson, et al.
Gynecologic Oncology|March 19, 2013
Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?Gunjal Garg, L Stewart Massad, Shabnam Pourabolghasem, et al.
Gynecologic Oncology Reports|June 14, 2019
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?Kathryn A Mills, Heather Lopez, Lulu Sun, et al.
Pageof 26

Showing results (91-100 of 256) with videos related to

Sort By:
Pageof 26
Gynecologic Oncology|October 22, 2008
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancerRebecca A Brooks, Janet S Rader, Farrokh Dehdashti, et al.
Annals of Surgical Oncology|September 6, 2014
Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancerL M Kuroki, M Mangano, J E Allsworth, et al.
Gynecologic Oncology|January 21, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcomaMichael D Toboni, Kaitlyn Dinkins, Sharon Wu, et al.
Gynecologic Oncology Reports|November 14, 2019
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumabJ Gillen, K A Mills, J Dvorak, et al.
Gynecologic and Obstetric Investigation|April 12, 2017
Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and TreatmentYevgeniya J Ioffe, Leslie Stewart Massad, Matthew A Powell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
EphA2 expression is associated with aggressive features in ovarian carcinomaPremal H Thaker, Michael Deavers, Joseph Celestino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 19, 2014
Targeting those with decreased meaning and peace: a supportive care opportunityAlaina J Brown, Charlotte C Sun, Diana Urbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptorsPremal H Thaker, Sertac Yazici, Monique B Nilsson, et al.
Gynecologic Oncology|March 19, 2013
Intestinal perforation in gynecologic oncology: do all patients benefit from surgical management?Gunjal Garg, L Stewart Massad, Shabnam Pourabolghasem, et al.
Gynecologic Oncology Reports|June 14, 2019
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?Kathryn A Mills, Heather Lopez, Lulu Sun, et al.
Pageof 26